Globus Medical Inc - Ordinary Shares - Class A
GMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.63B
Close$
$241.13
197.5% upside
Current Fair Value
197.5% upsideUndervalued by 197.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.63 Billion |
|---|---|
| Enterprise Value | $10.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.98 |
| Beta | 0.95 |
| Outstanding Shares | 135,364,000 |
Return
| Return on Equity | 12.40% |
|---|---|
| Return on Assets | 10.79% |
| Return on Invested Capital | 13.11% |
Valuation & Multiples
| P/E Ratio | 18.11 |
|---|---|
| PEG | 27.99 |
| Price to Sales | 3.68 |
| Price to Book Ratio | 2.38 |
| Enterprise Value to Revenue | 3.29 |
| Enterprise Value to EBIT | 15.71 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$1.10
Average shareholder expectationRevenue Estimate
$782.88 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 49.09% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.59%▼ 74.41% |
|---|---|
| Total Invested | $704.19M▼ 92.53% |
| Investors Holding | 199▼ 415.00% |
ESG Score
No data
About Globus Medical Inc
CEO: David Demski